רוקורוניום טבע ישראל - עברית - Ministry of Health

רוקורוניום טבע

teva pharmaceutical industries ltd, israel - rocuronium bromide - תמיסה להזרקה - rocuronium bromide 10 mg/ml - rocuronium bromide - rocuronium bromide - rocuronium teva is indicated as and adjunct to general anaesthesia to facilitate tracheal intubation during routine and rapid sequence induction, to provide skeletal muscle relaxation during surgery. rocuronium teva is also indicated as an adjunct in the intensive care unit (icu) to facilitate tracheal intubation and mechanical ventilation.

נורקורון 10 מ"ג ישראל - עברית - Ministry of Health

נורקורון 10 מ"ג

merck sharp & dohme israel ltd - vecuronium bromide 10 mg/vial - powder for solution for injection - vecuronium - adjunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.

נורקורון 4 מ"ג ישראל - עברית - Ministry of Health

נורקורון 4 מ"ג

merck sharp & dohme israel ltd - vecuronium bromide 4 mg/ml - powder for solution for injection - vecuronium - ajunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.

טרקריום להזרקה ישראל - עברית - Ministry of Health

טרקריום להזרקה

padagis israel agencies ltd, israel - atracurium besylate - תמיסה להזרקה - atracurium besylate 10 mg/ml - atracurium - atracurium - atracurium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation.

רנוולה אבקה 2.4 גרם ישראל - עברית - Ministry of Health

רנוולה אבקה 2.4 גרם

sanofi israel ltd - sevelamer carbonate anhydrous - אבקה להכנת תרחיף - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

אינפסורף ישראל - עברית - Ministry of Health

אינפסורף

rafa laboratories ltd - calfactant as phospholipid - תרחיף - calfactant as phospholipid 35 mg/ml - lung surfactants - infasurf is indicated for the prevention of respiratory distress syndrome (rds) in premature infants at high risk for rds and for the treatment ("rescue") of premature infants who develop rds. infasurf decreases the incidence of rds mortality due to rds and air leaks associated with rds. prophylaxis : prophylaxis therapy at birth with infasurf is indicated for premature infants <29 weeks of gestational age at significant risk for rds. infasurf prophylaxis should be administered as soon as possible preferably within 30 minutes after birth. treatment: infasurf therapy is indicated for infants 72 hours of age with rds (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.